HCPCS Code J3402

Injection, remestemcel-l-rknd, per therapeutic dose
Code effective Oct 01, 2025

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J3402 is a valid 2026 HCPCS code meaning Injection, remestemcel-l-rknd, per therapeutic dose or (Inj. remestemcel-l-rknd/ td) for short. HCPCS J3402 has been effective since 10/01/2025 and applies to Medical care.

HCPCS Code Details - J3402

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J3402
Description

Long description:
Injection, remestemcel-l-rknd, per therapeutic dose

Short description:
Inj. remestemcel-l-rknd/ td

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Oct 01, 2025
Date added Added Oct 01, 2025

See also

  • HCPCS J3401 · Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml

  • HCPCS J3403 · Revakinagene taroretcel-lwey, per implant

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.